| 000 | 01712 a2200517 4500 | ||
|---|---|---|---|
| 005 | 20250518073624.0 | ||
| 264 | 0 | _c20200220 | |
| 008 | 202002s 0 0 eng d | ||
| 022 | _a1178-2013 | ||
| 024 | 7 |
_a10.2147/IJN.S214657 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aJiang, Yueyao | |
| 245 | 0 | 0 |
_aThe Optimization Design Of Lactoferrin Loaded HupA Nanoemulsion For Targeted Drug Transport Via Intranasal Route. _h[electronic resource] |
| 260 |
_bInternational journal of nanomedicine _c2019 |
||
| 300 |
_a9217-9234 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAdministration, Intranasal |
| 650 | 0 | 4 |
_aAlkaloids _xpharmacokinetics |
| 650 | 0 | 4 |
_aAlzheimer Disease _xmetabolism |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 | _aBiological Transport |
| 650 | 0 | 4 |
_aBlood-Brain Barrier _xmetabolism |
| 650 | 0 | 4 |
_aBrain _xdrug effects |
| 650 | 0 | 4 | _aCell Line |
| 650 | 0 | 4 | _aDrug Liberation |
| 650 | 0 | 4 |
_aEmulsions _xchemistry |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLactoferrin _xadministration & dosage |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aNanoparticles _xadministration & dosage |
| 650 | 0 | 4 |
_aNasal Mucosa _xmetabolism |
| 650 | 0 | 4 | _aParticle Size |
| 650 | 0 | 4 | _aPhase Transition |
| 650 | 0 | 4 | _aRats, Wistar |
| 650 | 0 | 4 |
_aSesquiterpenes _xpharmacokinetics |
| 650 | 0 | 4 | _aSolubility |
| 650 | 0 | 4 | _aStatic Electricity |
| 650 | 0 | 4 | _aTissue Distribution |
| 700 | 1 | _aLiu, Chenqi | |
| 700 | 1 | _aZhai, Wanchen | |
| 700 | 1 | _aZhuang, Ning | |
| 700 | 1 | _aHan, Tengfei | |
| 700 | 1 | _aDing, Zhiying | |
| 773 | 0 |
_tInternational journal of nanomedicine _gvol. 14 _gp. 9217-9234 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.2147/IJN.S214657 _zAvailable from publisher's website |
| 999 |
_c30403299 _d30403299 |
||